| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is experiencing significant sales growth primarily driven by its weight loss drugs, Mounjaro and Zepbound, which have markedly boosted revenue figures. The company maintains a positive future growth outlook, supported by a robust product pipeline and strong market position. Despite recent stock declines, the demand for innovative weight loss solutions positions Eli Lilly favorably in an expanding market. Overall, the company appears well-equipped to navigate upcoming challenges and leverage growth opportunities. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.1 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.1, and the negative at -0.2 on 2025-05-06. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.4) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-06 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-05-05 | 0%(0%) | 0 | 0% | 0.1 | 1.5 | -1 | |||||||
| 2025-05-04 | 0%(0%) | 0 | 0% | 0 | 1 | -1 | |||||||
| 2025-05-03 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-05-02 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-05-01 | 0%(0%) | 0 | 0% | 0 | 1.1 | -1 | |||||||
| 2025-04-30 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| 2025-04-29 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-04-28 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-04-27 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:05:40 Eli Lilly's guidance reduction and overall outlook suggests leadership challenges and impacts on investor trust and company valuation. |
| 2025-05-19 17:05:40 Concerns over Eli Lilly's legal challenges and investigations into the company's practices reflect broader issues of compliance and securities law within the sector. |
| 2025-05-19 17:05:40 The articles point to varying stock performances among competing pharmaceutical companies, indicating competitive pressures and market reactions. |
| 2025-05-19 17:05:40 The reactiveness of investors to earnings reports is highlighted, with significant stock movements reflecting investor confidence or lack thereof, particularly for companies like Hims & Hers and Eli Lilly. |
| 2025-05-19 17:05:40 The articles discuss various challenges and headwinds facing the pharmaceutical sector, including potential impacts on stock performance and company earnings. |